Schedule 13G ownership disclosure
CELLECTAR BIOSCIENCES INC
Security class unavailable · CUSIP: 15117F500
Event date: 2024-07-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,671,550
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001622627-24-000046
- Form type
- SC 13G
- Filer
- Cellectar Biosciences, Inc.
- CIK
- CIK 1279704
- Filed
- Aug 14, 2024
- Reporting period
- Jul 25, 2024
- Description
- Schedule 13G beneficial ownership